Shots:

• The companies will co-develop a first-of-its-kind- single-use flow-through polishing system for GMP operation. The collaboration expected to accelerate affordable access to therapeutics for patients in China and globally
• The agreement will initially focus on developing and designing the process technologies and automation while later focus on the expanded scope of the process and digital technologies to optimize a continuous manufacturing process
• The collaboration leverages Merck's BioContinuum platform and expertise in continuous processing to aid Transcenta's vision in implementing fully continuous bioprocessing in GMP manufacturing in China

 ­ Ref: PRNewswire | Image: Merck